Received Feb 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 2 | 1965045 | — |
No additional AE; expired dose of GARDASIL 9 administered; This spontaneous report was received from Medical Assistant on 24-Feb-2026 and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 21-Jan-2026, the patient was vaccinated with a second expired dose of with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) prefilled syringe (lot #1965045, expiration date: 19-Jan-2026), dose:0.5 mL, total, for prophylaxis. The vaccine was administered by a health care professional.The patient involved did not experience any medical concerns after being administered with the expired dose. No adverse event reported.